-
Nu.Q® Technology
Our technology detects characteristic epigenetic changes in nucleosomes that occur from the earliest stages of cancer, sepsis and other diseases.
-
- Our Tests
- Human Health
-
Nu.Q® NETs
Nu.Q® NETs is a groundbreaking CE-marked diagnostic solution that clinicians can use to detect NETosis.
-
Nu.Q® Discover
Buy our Nu.Q® Discover H3.1 Research Use Only Assay
- Animal Health
-
Nu.Q® Vet Cancer Test
Nu.Q® Vet Cancer Test detects 76% of systemic cancers at 97% specificity.
Careers at Volition.
Join our team working for a brighter tomorrow
Join a team working for a brighter tomorrow.
We are determined to improve health outcomes for people worldwide, through the earlier diagnosis and monitoring of disease. Our team is committed to achieving this goal, bringing their passion, skills, ideas, and dedication to Volition each day.
If you have drive and determination, believe in our vision and values, and are committed to collaborative working, we want to hear from you.
About Volition
We are a global team driven by shared values. We have sites in America, Europe and Asia.
Working together, our team is dedicated to revolutionizing the diagnosis and monitoring of life-altering diseases by advancing the science of epigenetics.
Our values
That’s why we named ourselves Volition, to honor the central importance and absolute focus of that purpose and determination in revolutionizing the way disease is diagnosed and monitored.
We believe in ourselves
We believe wholeheartedly in the power of our technology, our products, and our people. Nucleosomics™ technology has the potential to play an important role in the fight to save lives and improve outcomes worldwide. This belief and passion are what drive and sustain us and everyone who joins us.
We act with humility
We are inspired every day by the potential of what we do and what we can achieve together. Our horizon is continuously expanding beyond cancer to a whole range of life-altering diseases, beyond humans to animals, to find and address a host of unmet clinical needs, always with the patient at the forefront of our minds.
We are in this together, for everyone
The science of what we do is detailed and complex, but Nu.Q® itself is not. A simple, routine blood test, like a blood sugar or cholesterol test, our goal is that Nu.Q® will be affordable and available to all. And this is the essence of who we are. We are in this together, for everyone.
We dare to be different
What we do and the way we do it is completely unique. We dare to challenge the status quo to advance the science of epigenetics and improve outcomes for people and animals worldwide. We seek to change the world by allowing physicians to use the hidden information in chromosomes to detect disease earlier, monitor it more effectively and help improve outcomes.
We strive to be the best
Our team are leading experts in epigenetics. For over a decade we have evolved and mastered our understanding of nucleosomes. We have developed and refined our technology to be what we believe to be the best-in-class in the diagnostics industry. Everything we do, we do to the very best of our ability.
Meet our team
Meet Marielle Herzog, our R&D Director. Marielle joined us in 2011 and plays an integral role at Volition. Find out more about her career path, the growth of Volition, and her belief in the power of dedication and teamwork.
I could not be more proud of the team we have put together who come to work every day to create a brighter future.
Cameron Reynolds
President and Group Chief Executive Officer
Lead the way with us.
If you have drive and determination, believe in our vision and values, and are committed to collaborative working, we want to hear from you.
To apply, browse through our vacancies, download the job description and then submit your application via our online portal section.